A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

Urologists, radiologists and pathologists from Europe and the US agreed an “expert consensus statement” on prostate cancer treatment and diagnosis ...

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

Prostate cancer is one of the most common cancers affecting men around the world. It develops in the prostate, a small gland ...

Among prostate cancer patients under active surveillance, low testosterone levels were associated with a statistically significant increased risk of "extreme" progression to grade group 3 or higher ...

Prostate cancer is one of the leading causes of cancer-related death in men, and some experts project the number of cases to rise over the coming decades. But in a recent Urologic Oncology article, ...

Brian Holmes is the first man in the UK and only the fifth in the world to take part in the clinical trial A prostate cancer ...

UK surgeons remotely removed a man’s prostate cancer from 1,500 miles away in the country’s first successful robot-assisted telesurgery.

New AI algorithms could help detect prostate cancer more efficiently, according to a doctor with Cleveland Clinic.

Leapman, MD, MHS, associate professor of urology at Yale University, addresses a critical and often overlooked limitation in the current landscape of prostate cancer biomarkers: while these tools have ...

Although immunotherapy progress in prostate cancer has been slow, emerging strategies like bispecific T-cell engagers (BiTEs) show promise in overcoming historical resistance. In a recent discussion, ...

A personalized peptide vaccine slashed prostate-specific antigen levels by as much as 99.6% in some men with advanced prostate cancer, according to a phase II clinical trial conducted at Kurume ...